Centro Médico Punta Cana in collaboration with Medias Klinikum in Germany present a service for cancer patients who seek to prolong life and improve their quality by receiving premium medical care against cancer.SCHEDULE AN APPOINTMENT
At our private hospital, we have state-of-the-art technology housed in one of the most impressive healthcare facilities in the Dominican Republic, and supported by an international accreditation from Acreditation Canada. This combination of quality and innovation offers an innovating solution for cancer patients seeking alternatives to traditional chemotherapy.
Located in the main tourist destination of Punta Cana, the area is not only distinguished by its beautiful beaches with crystalline waters and the smiles of its people, but also by its delicious Dominican cuisine. Now, patients no longer have to travel to Germany to receive this type of treatment, as we offer an ideal location in the Caribbean for their recovery.
Regional Chemotherapy (RCT) is an innovative and less invasive procedure that focuses on delivering chemotherapy directly through the artery that supplies the tumor, allowing the application of a concentrated dose to the cancer cells in the affected area.
This approach significantly reduces the side effects associated with traditional chemotherapy, since the amount of drug reaching other parts of the body is minimal. After the therapy is finished, the blood is cleaned by chemofiltration and excess drug is removed. This process helps further reduce side effects for the patient.Types of RCT Techniques
Among the publications and tumor diseases treated with regional chemotherapy (RCT), best results are found in:
About 5% of new cancers arise in the head and neck. Most are squamous cell carcinomas that originate in the mucous membrane and can spread rapidly. Regional intra-arterial infusion chemotherapy is an effective therapeutic option for these tumors.
After three therapies, the overall response rate for breast cancer was 74%, which means that the size of the tumor was reduced. The patients' quality of life was good, side effects were mild and most were able to work between treatment cycles.
Current standard treatment is often associated with significant side effects. Induction chemotherapy can reduce the size of the tumor. Some patients showed a complete response and all patients remained tumor free for up to 15 years after treatment.
Although many patients respond well to chemotherapy, it often relapses within two years. Important prognostic factors include the stage of the cancer, residual tumor, and time to recurrence. Regional chemotherapy can reduce existing chemoresistance.
Pancreatic carcinoma is a cancer with a poor prognosis and a low survival rate. Regional chemotherapy has shown improvements in patient survival and tumor response.
Regional chemotherapy offers a therapeutic approach with few side effects and a survival advantage over currently recommended options for advanced metastatic gastric cancer.
Esophageal cancer is a disease with a low survival rate. With conventional treatment, most patients do not survive more than 10 months after diagnosis. However, regional chemotherapy has been shown the median overall survival was 38 months, with 57% of patients surviving beyond 22 months.
Osteosarcoma is a rare and aggressive type of cancer that usually affects young people between the ages of 14 and 19. There are cases that require the amputation of the affected member. However, with regional chemotherapy in conjunction with chemofiltration, the tumor can be shrunk and allow sparing surgery of the affected limb.
The use of regional chemotherapy depends on the type of tumor to be treated, the general condition of the patient, whether or not they have received previous treatment, and other factors.
Find out if your case can be treated with this type of therapy. Complete the following questionnaire to determine if you could benefit from these treatments.Evaluate your case
With regional chemotherapy we give a new direction to cancer treatment, one that allows people to maintain their quality of life.
Dr. Karl Reinhard Aigner is a vascular surgeon and oncologist, with more than 40 years of experience in this field and is considered a pioneer of Regional Chemotherapy worldwide.
Dr. Miguel Monanci is a leading clinical oncologist graduated from Universidad del Este in San Pedro de Macorís. He is President of the Dominican Society of Oncology and works at the Dr. Heriberto Pieter Institute of Oncology. Currently, he is part of the oncology committee of the Aigner Rescue Clinic at the Punta Cana Medical Center.
Dr. Juan Elvin Muñoz Jiménez is a distinguished and outstanding Laparoscopic General Surgeon who currently serves as the leading General Surgeon at the Punta Cana Medical Center and Aigner-Rescue Clinic of Selective Regional Chemotherapy. He operates with dedicated excellence and is renowned for his expertise in advanced surgical techniques.
Dr. Álbida De León, a highly respected doctor at Centro Médico Punta Cana. With years of experience in anesthesiology and medical care in the Dominican Republic, she has become a prominent leader in her field and is part of the oncology team at the Aigner-Rescue Clinic.
Know more from our patients who received a life opportunity thanks to RCT